- Home
- ACB vs LFCR Comparison
ACB vs LFCR Comparison
Compare ACB & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACB
- LFCR
- Stock Information
- Founded
- ACB 2013
- LFCR 1986
- Country
- ACB Canada
- LFCR United States
- Employees
- ACB N/A
- LFCR N/A
- Industry
- ACB Pharmaceuticals and Biotechnology
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- ACB Health Care
- LFCR Health Care
- Exchange
- ACB Nasdaq
- LFCR Nasdaq
- Market Cap
- ACB 257.9M
- LFCR 218.8M
- IPO Year
- ACB N/A
- LFCR N/A
- Fundamental
- Price
- ACB $5.89
- LFCR $5.61
- Analyst Decision
- ACB Hold
- LFCR Buy
- Analyst Count
- ACB 1
- LFCR 3
- Target Price
- ACB N/A
- LFCR $8.00
- AVG Volume (30 Days)
- ACB 6.7M
- LFCR 127.0K
- Earning Date
- ACB 02-05-2025
- LFCR 01-02-2025
- Dividend Yield
- ACB N/A
- LFCR N/A
- EPS Growth
- ACB N/A
- LFCR N/A
- EPS
- ACB 0.07
- LFCR N/A
- Revenue
- ACB $222,964,332.00
- LFCR $130,858,000.00
- Revenue This Year
- ACB $19.90
- LFCR $2.24
- Revenue Next Year
- ACB $5.80
- LFCR $7.88
- P/E Ratio
- ACB $92.30
- LFCR N/A
- Revenue Growth
- ACB 20.72
- LFCR 16.47
- 52 Week Low
- ACB $2.84
- LFCR $3.68
- 52 Week High
- ACB $9.35
- LFCR $8.45
- Technical
- Relative Strength Index (RSI)
- ACB 60.56
- LFCR 38.75
- Support Level
- ACB $5.67
- LFCR $5.59
- Resistance Level
- ACB $6.83
- LFCR $6.39
- Average True Range (ATR)
- ACB 0.57
- LFCR 0.29
- MACD
- ACB 0.04
- LFCR 0.01
- Stochastic Oscillator
- ACB 70.76
- LFCR 2.50
About ACB Aurora Cannabis Inc.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.